Skip to content

Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions

Namik Kirlic, Molly Lennard-Jones, Merve Atli, Ekaterina Malievskaia, Don Koelpin, Nadav Liam Modlin, Stéphanie Knatz Peck, A.w.k. Gaillard, Guy M. Goodwin

American Journal of Psychiatry January 1, 2025 DOI: 10.1176/appi.ajp.20230884 via OpenAlex

Summary

AI-generated from the abstract

A structured framework called the Compass Psychological Support Model (CPSM) provides psychological support for individuals with treatment-resistant depression receiving investigational psilocybin treatment in clinical trials. The model aims to ensure a safe and meaningful psychedelic experience and enables future research into which aspects of psychological support or psychotherapy best complement psilocybin treatment. The authors describe therapist training, mentoring, and fidelity assessment programs developed to maintain quality and consistency in delivering the CPSM.

Study at a glance

Characteristics Theoretical or philosophical paper Peer reviewed
Population Participants with treatment-resistant depression in Compass-sponsored clinical trials of investigational COMP360 psilocybin treatment
Intervention Compass Psychological Support Model (CPSM)
Topics Psilocybin
Keywords Mental health Psychotherapist Compass Hallucinogen
Citations 27
Key finding The Compass Psychological Support Model provides a structured framework for psychological support during investigational psilocybin treatment, with associated therapist training and fidelity programs.

Abstract

The psychedelic experience can be challenging. There is a need for a structured framework for providing psychological support to individuals with mental health conditions receiving investigational psilocybin treatment. The primary benefit of such a framework is to support a safe and meaningful psilocybin experience. It also enables future research on the facets of psychological support and/or psychotherapy that most optimally complement psilocybin treatment. The authors describe the Compass Psychological Support Model (CPSM), currently used to support participants with treatment-resistant depression in Compass-sponsored clinical trials of investigational COMP360 psilocybin treatment. The authors also outline the therapist training, mentoring, and fidelity assessment programs they have developed to ensure the quality and consistency of the CPSM delivery.

Explore topics

Comments

No comments yet.

Log in to comment